| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shuhua Yang, Qing Gao, Lihua Bao, Jing Zhang, Yanlai Hu, Lujun Bing, Jinlong Sun, Jing Hao, Chao Chen, Shangzhi Li, W S Poon, Jinhao Sun, Yingmao Ga. Striatal extracts promote the dopaminergic differentiation of GFP-bone mesenchymal stem cells. Neuroscience letters. vol 530. issue 2. 2013-05-09. PMID:23069670. |
because the striatum is the target tissue for the projection of da neurons in the midbrain, we investigated whether its extracts could promote the dopaminergic differentiation of bmscs. |
2013-05-09 |
2023-08-12 |
mouse |
| M Lenard Lachenmayer, Zhenyu Yu. Genetic animal models for evaluating the role of autophagy in etiopathogenesis of Parkinson disease. Autophagy. vol 8. issue 12. 2013-05-08. PMID:22931754. |
parkinson disease (pd) is the most common neurodegenerative movement disorder and is characterized pathologically by the formation of ubiquitin and snca/α-synuclein-containing inclusions (lewy bodies), dystrophic midbrain dopaminergic (daergic) terminals, and degeneration of midbrain daergic neurons. |
2013-05-08 |
2023-08-12 |
Not clear |
| Björn Spittau, Xiaolai Zhou, Ming Ming, Kerstin Krieglstei. IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. Neuromolecular medicine. vol 14. issue 4. 2013-05-07. PMID:22772723. |
il6 protects mn9d cells and midbrain dopaminergic neurons from mpp+-induced neurodegeneration. |
2013-05-07 |
2023-08-12 |
Not clear |
| Björn Spittau, Xiaolai Zhou, Ming Ming, Kerstin Krieglstei. IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. Neuromolecular medicine. vol 14. issue 4. 2013-05-07. PMID:22772723. |
the degeneration of midbrain dopaminergic (mda) neurons is the hallmark of parkinson's disease (pd), and several in vivo and in vitro models have been established to resemble the processes occurring during disease progression. |
2013-05-07 |
2023-08-12 |
Not clear |
| Jakob Linnet, Kim Mouridsen, Ericka Peterson, Arne Møller, Doris Jeanne Doudet, Albert Gjedd. Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry research. vol 204. issue 1. 2013-05-06. PMID:22889563. |
two mechanisms of midbrain and striatal dopaminergic projections may be involved in pathological gambling: hypersensitivity to reward and sustained activation toward uncertainty. |
2013-05-06 |
2023-08-12 |
Not clear |
| Lukáš Čajánek, Ranjani Sri Ganji, Catarina Henriques-Oliveira, Spyridon Theofilopoulos, Peter Koník, Vítězslav Bryja, Ernest Arena. Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons. Molecular and cellular biology. vol 33. issue 1. 2013-04-26. PMID:23109420. |
tiam1 regulates the wnt/dvl/rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons. |
2013-04-26 |
2023-08-12 |
Not clear |
| Maryna Baydyuk, Yuxiang Xie, Lino Tessarollo, Baoji X. Midbrain-derived neurotrophins support survival of immature striatal projection neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 33. issue 8. 2013-04-24. PMID:23426664. |
here we report that brain-derived neurotrophic factor and neurotrophin-3 are anterogradely transported from midbrain dopaminergic neurons and support the survival of immature msns of the indirect and direct pathways, respectively, in the developing mouse striatum and lge. |
2013-04-24 |
2023-08-12 |
mouse |
| Guillem R Esber, Matthew R Roesch, Shreya Bali, Jason Trageser, Gregory B Bissonette, Adam C Puche, Peter C Holland, Geoffrey Schoenbau. Attention-related Pearce-Kaye-Hall signals in basolateral amygdala require the midbrain dopaminergic system. Biological psychiatry. vol 72. issue 12. 2013-04-23. PMID:22763185. |
attention-related pearce-kaye-hall signals in basolateral amygdala require the midbrain dopaminergic system. |
2013-04-23 |
2023-08-12 |
Not clear |
| Guillem R Esber, Matthew R Roesch, Shreya Bali, Jason Trageser, Gregory B Bissonette, Adam C Puche, Peter C Holland, Geoffrey Schoenbau. Attention-related Pearce-Kaye-Hall signals in basolateral amygdala require the midbrain dopaminergic system. Biological psychiatry. vol 72. issue 12. 2013-04-23. PMID:22763185. |
this requirement for prediction errors, coupled with projections from the midbrain dopamine system into basolateral amygdala, suggests that the pkh signal in amygdala may depend on dopaminergic input. |
2013-04-23 |
2023-08-12 |
Not clear |
| Michal Sheleg, Carrie L Yochum, George C Wagner, Renping Zhou, Jason R Richardso. Ephrin-A5 deficiency alters sensorimotor and monoaminergic development. Behavioural brain research. vol 236. issue 1. 2013-04-23. PMID:22954718. |
previously, we demonstrated that ephrin-a5 acts as a guidance molecule regulating the trajectory of the ascending midbrain dopaminergic pathways. |
2013-04-23 |
2023-08-12 |
mouse |
| S J Moeller, D Tomasi, J Honorio, N D Volkow, R Z Goldstei. Dopaminergic involvement during mental fatigue in health and cocaine addiction. Translational psychiatry. vol 2. 2013-04-23. PMID:23092980. |
during such mental fatigue (indicated by increased errors, and decreased post-error slowing and dorsal anterior cingulate response to error as a function of time-on-task), healthy individuals showed increased activity in the dopaminergic midbrain to error. |
2013-04-23 |
2023-08-12 |
human |
| S J Moeller, D Tomasi, J Honorio, N D Volkow, R Z Goldstei. Dopaminergic involvement during mental fatigue in health and cocaine addiction. Translational psychiatry. vol 2. 2013-04-23. PMID:23092980. |
together, these multimodal imaging findings suggest a novel involvement of the dopaminergic midbrain in sustaining motivation during fatigue. |
2013-04-23 |
2023-08-12 |
human |
| Michael Y Aksenov, M V Aksenova, C F Mactutus, Rosemarie M Booz. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 7. issue 3. 2013-04-10. PMID:22552781. |
the effects of d1- and nmda-receptor specific antagonists (sch23390 and mk-801, respectively) on the neurotoxicity of different doses of meth or hiv-1 tat alone and on the meth + hiv-1tat interaction in midbrain neuronal cultures suggest that the induction of the cell death cascade by meth and tat requires both dopaminergic (d1) and n-methyl d-aspartate (nmda) receptor-mediated signaling. |
2013-04-10 |
2023-08-12 |
Not clear |
| Terina N Martinez, Xi Chen, Sibali Bandyopadhyay, Alfred H Merrill, Malú G Tanse. Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons. Molecular neurodegeneration. vol 7. 2013-04-09. PMID:22973882. |
dopaminergic (da) neurons in the ventral midbrain selectively degenerate in parkinson's disease (pd) in part because their oxidative environment in the substantia nigra (sn) may render them vulnerable to neuroinflammatory stimuli. |
2013-04-09 |
2023-08-12 |
rat |
| Emma R Andersson, Carmen Saltó, J Carlos Villaescusa, Lukas Cajanek, Shanzheng Yang, Lenka Bryjova, Irina I Nagy, Seppo J Vainio, Carmen Ramirez, Vitezslav Bryja, Ernest Arena. Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proceedings of the National Academy of Sciences of the United States of America. vol 110. issue 7. 2013-04-08. PMID:23324743. |
wnt5a cooperates with canonical wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. |
2013-04-08 |
2023-08-12 |
mouse |
| Emma R Andersson, Carmen Saltó, J Carlos Villaescusa, Lukas Cajanek, Shanzheng Yang, Lenka Bryjova, Irina I Nagy, Seppo J Vainio, Carmen Ramirez, Vitezslav Bryja, Ernest Arena. Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proceedings of the National Academy of Sciences of the United States of America. vol 110. issue 7. 2013-04-08. PMID:23324743. |
two of them, wnt1 and wnt5a, activate distinct branches of wnt signaling and individually regulate different aspects of midbrain dopaminergic (da) neuron development. |
2013-04-08 |
2023-08-12 |
mouse |
| Arthur Leblois, David J Perke. Striatal dopamine modulates song spectral but not temporal features through D1 receptors. The European journal of neuroscience. vol 35. issue 11. 2013-04-04. PMID:22594943. |
the activity of midbrain dopaminergic neurons and their projection to the basal ganglia (bg) are thought to play a critical role in the acquisition of motor skills through reinforcement learning, as well as in the expression of learned motor behaviors. |
2013-04-04 |
2023-08-12 |
Not clear |
| Xiaotian Sun, Jin Liu, John F Crary, Cristina Malagelada, David Sulzer, Lloyd A Greene, Oren A Lev. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 33. issue 6. 2013-04-01. PMID:23392669. |
atf4 was also protective against 6-ohda-induced death of cultured mouse ventral midbrain dopaminergic neurons. |
2013-04-01 |
2023-08-12 |
mouse |
| F L Campos, A C Cristovão, S M Rocha, C P Fonseca, G Baltaza. GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones. Journal of neuroendocrinology. vol 24. issue 11. 2013-03-28. PMID:22672424. |
gdnf contributes to oestrogen-mediated protection of midbrain dopaminergic neurones. |
2013-03-28 |
2023-08-12 |
human |
| Daniel J Costello, Gerard W O'Keeffe, Fiona M Hurley, Aideen M Sulliva. Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease. Journal of cellular and molecular medicine. vol 16. issue 10. 2013-03-26. PMID:22436046. |
growth/differentiation factor 5 (gdf5) is a neurotrophic factor that promotes the survival of midbrain dopaminergic neurons in vitro and in vivo and as such is potentially useful in the treatment of parkinson's disease (pd). |
2013-03-26 |
2023-08-12 |
human |